Drug
Gevokizumab
Gevokizumab: highest development phase Phase 3, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| Gevokizumab NCT01965145 | Phase 3 | Behcet's Uveitis |
Latest
No recent events.
Follow Gevokizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.